$599

Dual/triple agonist, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other, Topics

March 18, 2025

CMS Price Negotiation Update; Ypsomed and CamDiab Launch mylife Loop on iOS

Two cardiometabolic-related news items have been observed: all 15 drug manufacturers agreed to participate in the second round CMS pricing negotiations (view press release) and Ypsomed and CamDiab launched mylife Loop on iOS systems (view press release).

This content is for Read Less members only.
Register

Already a member? Log in here

Return to Home